01. Why pharma SEO is uniquely hard
Pharma SEO is the highest-stakes vertical in Indian search. You're competing against enormous legacy players, Google's YMYL guidelines apply, and one wrong content page can invite scrutiny from CDSCO or the DMR Act. Yet the demand is real — Indian search volume for pharma B2B queries grew 41% YoY in 2025. Ignoring it is a strategic error.
02. The E-E-A-T-first content model
Google's YMYL bar in pharma is E-E-A-T squared. Every page needs: (1) a named medical / pharma reviewer with credentials, (2) source citations from PubMed / WHO / ICMR, (3) an updated-on date, and (4) unambiguous claims. We audit every pharma content page with an internal 12-point compliance checklist before publish. Skip this at your peril.
03. Keyword architecture for pharma B2B
Prioritise commercial-intent B2B keywords first (“bulk paracetamol supplier India”, “contract manufacturing pharma Baddi”), then niche informational (“CDSCO Schedule H compliance”), then broad awareness. The mistake most pharma marketers make is chasing broad terms first — the ROI is invisible for 12+ months.
04. Technical SEO essentials pharma sites always fail
Common issues we find in 90% of pharma audits: massive product catalogues with duplicate meta, hreflang misconfiguration for multi-country brands, painfully slow LCP due to heavy imagery, and structured data absent on product + FAQ pages. Fixing these alone typically adds 30–60% organic traffic within a quarter.
05. Link building without regulatory pain
Digital PR through medical journals, university partnerships, and industry association memberships. We avoid guest-post networks entirely — they invite penalties and reputational risk. Slow but compounding.
Tags:SEOPharmaHealthcareContent Marketing
Frequently Asked Questions
Can we run PPC ads for prescription drugs in India?+
No. Both Google and Meta prohibit ads for prescription and Schedule H drugs. Organic SEO + LinkedIn thought leadership are the only scalable channels.
How long until pharma SEO shows results?+
Realistic timeline is 6–12 months for meaningful commercial-intent rankings. Informational content can rank in 3–6 months.
Do we need a separate content team for compliance review?+
Yes. We include compliance review workflows in every pharma engagement — typically a retained medical reviewer at 4–8 hours/month.